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Introduction
The genetic etiology of DiGeorge syndrome (DGS) involves a 3 Mbp microdeletion of the DiGeorge critical region (DGCR) on human chromosome 22q11.2, thus it is also known as del22q11.2 syndrome. Cardiovascular defects observed in DGS, such as interrupted aortic arch and ventricular septal defect (VSD) are also observed in several mouse experimental models, in which the expression of genes annotated to the microdeletion 22q11.2 was perturbed (Lindsay, 2001) . However, recapitulation of the full-blown human phenotype, including persistent truncus arteriosus (PTA) requires homozygous deletion of 22q11.2 genes, such as Tbx1, suggesting that other genes potentially contribute to DGS pathogenesis.
Indeed, many other mouse models provided important genetic insights into the development of the cardiovascular system and its associated diseases, including Crkl, TGFbr2, ERK1/2 and Shp2 (Guris et al., 2001; Nakamura et al., 2009; Newbern et al., 2008; Wurdak et al., 2005) . Many of these experimental models focus on the cardiac neural crest cells (cNCCs), a unique subset of cells that migrate from the dorsal aspect of the neural tube to remodel the pharyngeal arch arteries (PAAs) and the septation of the cardiac outflow tract (OFT) into two individual vessels: the pulmonary trunk and ascending aorta (Hutson and Kirby, 2007) . Thus, neural crest (NC)-specific knockout models have proved useful in unraveling facets of the molecular network governing OFT development and in addition provided tools to study genes that hold different dosage threshold between the mouse and the human cardiovascular systems (High et al., 2007; Lepore et al., 2006; Vallejo-Illarramendi et al., 2009) . microRNAs (miRNAs) have emerged as central regulators of NC and cardiovascular development (Cordes et al., 2009; Small and Olson, 2011; Xin et al., 2009) . The maturation of most miRNAs is governed by the microprocessor complex, composed of the RNase III-like enzyme DROSHA and the RNA-binding protein, DGCR8 (Seitz and Zamore, 2006) . As suggested by its name, Dgcr8 is mapped within the 22q11.2 DGCR locus (and the syntenic region on mouse chromosome 16), making it a potentially important component in the pathogenesis of DGS (Shiohama et al., 2003) . Furthermore, disruption of Dgcr8 results in behavioral and neuronal deficits characteristic of DGS (Schofield et al., 2011; Stark et al., 2008) . Therefore, we sought to analyze the potential role of Dgcr8 in cardiovascular development. Here, we describe congenital heart abnormalities that result from genetic inactivation of a Dgcr8 conditional allele in neural crest cells (NCCs).
Materials and methods

Mouse genetics
Dgcr8 conditional allele (Wang et al., 2007) was crossed to a transgenic Cre line under the control of the Wnt1 promoter (a gift from Andrew McMahon). To generate Dgcr8 conditional knockout embryos, Wnt1-cre;Dgcr8 loxp/+ males were crossed with Dgcr8 loxp/loxp females. R26R-lacZ or R26R-YFP reporter lines, generously shared by P. Soriano and F. Constantini, respectively, were crossed into the Dgcr8 loxp/loxp females for genetic fate tracing.
Intracardial ink injection
India ink was injected into the embryo left ventricle using a pulled capillary tube. Injected embryos were subsequently fixed in 4% PFA overnight, dehydrated by graded methanol washes and cleared in benzyl benzoate: benzyl alcohol (1:1).
Histology, immunochemistry and proliferation assays
Embryos were collected at stages of interest, rinsed in PBS, fixed overnight in 4% buffered paraformaldehyde at 4°C, dehydrated through a series of ethanol baths and embedded in Paraplast Plus (McCormick Scientific) . Paraffin sections were subjected to hematoxylin-Eosin staining or to immunofluorescent analysis: Following rehydration, slides were incubated in 10 mmol/L sodium citrate buffer pH6.0 on a 2100 Retriever (PickCell Laboratories) for a period of 3 h. Slides were then washed in DDW, PBS and 0.1% Tween (Sigma) and blocked with CAS-Block (Invitrogen) for 10 min at room temperature. Primary antibodies in CAS-Block were incubated overnight at 4°C: DGCR8 (10996-1-AP, 1:100 dilution, Proteintech), GFP (ab6658, 1:300, Abcam), Smooth muscle α-actin (A 2547, 1:400, DAKO), cleaved Caspase-3 (9661, 1:300, Cell Signaling Technology). For proliferation assay, 1 h after injection of BrdU at 100 μg/g body weight (Sigma), embryos were harvested and fixed in 4% paraformaldehyde. Detection of BrdU-labeled cells was performed by using an anti-BrdU antibody (RPN202, 1:300, GE Healthcare). Cyanine conjugated anti-rabbit, anti-mouse or antigoat secondary antibodies (1:100, ImmunoResearch Laboratories) were added in CAS-Block for 1 h at room temperature. 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI) was added for 5 min before slides were mounted with Immu-mount (Thermo Scientific).
Fluorescent images were captured with a Nikon 90i mounted with Nikon D5-SM camera or a Zeiss LSM510 Laser Scanning confocal microscopy system.
Whole mount RNA in situ hybridization
Embryos were harvested and fixed in 4% paraformaldehyde overnight at 4°C and dehydrated in graded methanols. DIG-labeled antisense RNA probes for Crabp1 and Ap2-alpha were transcribed in vitro (Roche Applied Science) following manufacturer's instructions.
Whole mount β-galactosidase staining
Embryos were fixed in fresh 4% paraformaldehyde at 4°C for 30 min, thoroughly washed with PBS, supplemented with 0.02% NP-40 (Sigma) and developed in 20 mmol/L potassium ferricyanide, 20 mmol/L potassium ferrocyanide, 2 mmol/L magnesium chloride and 0.4 mg/mL X-gal substrate in PBS, 0.02% NP-40, at 37°C for 4 h. Some embryos were further paraffin embedded and sectioned.
Results
Deletion of Dgcr8 in NCCs leads to severe cardiovascular defects cNCCs remodel the PAAs and enable septation of the cardiac OFT into the pulmonary artery and the aorta (Hutson and Kirby, 2007) . To assess Dgcr8 requirement in PAAs and OFT development, we generated Wnt1-cre;Dgcr8 loxp/loxp mice by crossing a Dgcr8 conditional allele (Wang et al., 2007) onto a Cre transgene that is driven by the Wnt1 promoter. NC-specific Cre activity resulted in loss of DGCR8
Severe cardiovascular malformations observed in Dgcr8 mutants. Sagittal aortic arch sections of E10.5 Wnt1-cre;Dgcr8 loxp/+ ;R26R-YFP controls (A, n = 3) and Wnt1-cre; Dgcr8 loxp/loxp ;R26R-YFP mutants (B, n = 4) stained for YFP (green) and DGCR8 (red). Magnified view in insets. (C-E) Gross thorax anatomy of E17.5 controls (C, n = 10) and Wnt1-cre;Dgcr8 loxp/loxp mutants (D-E, n = 11) and respective schemes of the great vessels (C′-E′). All Wnt1-cre;Dgcr8 loxp/loxp displayed persistent truncus arteriosus (PTA; D′,E′ n = 11/11), while additional abnormalities included interrupted aortic arch type B (IAA; E′ n = 3/11), aberrant origin of the right subclavian artery (Ab-RSA; D′ n = 3/11) and cervical aortic arch (Cx-AA; D′ n = 2/11). RSA, right subclavian artery; RCC, right common carotid; IA, inominate artery; LSA, left subclavian artery; LCC, left common carotid; AA, aortic arch; Ao, aorta; DA, ductus arteriosus. Anterior (top) view of E18.5 OFT, divided into pulmonary artery and aorta in healthy controls (F) and displays persistent truncus arteriosus in Wnt1-cre;Dgcr8 loxp/loxp (G). H&E staining of representative E18.5 frontal heart sections from controls (H, n = 3) and Wnt1-cre;Dgcr8 loxp/loxp mutants (I, n = 3), the latter manifests with persistent truncus arteriosus (PTA) and ventricular septal defect (VSD). Ao, aorta; PA, pulmonary artery; RV, right ventricle; LV, left ventricle. Frontal view of E18.5 control thymus (J, n = 4) and Wnt1-cre;Dgcr8 loxp/loxp thymus that is malformed and ectopically positioned, in a lateral situs in the thorax (K, n = 3). LT, left thymic lobe; RT, right thymic lobe; Tr, trachea.
and also in induction of a ROSA26 YFP-knock-in reporter transgene (R26R-YFP) ( Figs. 1A,B ). Since DGCR8 was not detected at embryonic day (E) 10.5 in Wnt1-cre;Dgcr8 loxp/loxp NC-descendants, that were recognized by activation of the R26R-YFP reporter, we conclude that Cre mediated recombination efficiently disrupted the Dgcr8 gene ( Figs. 1A,B ). While Wnt1-cre;Dgcr8 loxp/+ and Dgcr8 loxp/loxp mice were phenotypically normal and taken as controls throughout this study, Wnt1-cre; Dgcr8 loxp/loxp littermates died perinatally. Gross anatomical exploration of Wnt1-cre;Dgcr8 loxp/loxp mice revealed major cardiovascular defects at E18.5, including PTA (100%), interrupted aortic arch (27%), cervical aortic arch (18%) and aberrant origin of the right subclavian artery (27%) (Figs. 1C-G). Coronal sections of dissected Wnt1-cre;Dgcr8 loxp/loxp hearts further revealed a VSD (Figs. 1H,I). In addition we noted hypoplastic, malpositioned thymi (Figs. 1J,K) and craniofacial abnormalities (Fig.  S1 ). This spectrum of defects is reminiscent of human cardiovascular diseases, including manifestations described in DGS.
Initial pharyngeal arch artery formation is not disrupted in Dgcr8 mutants
To study potential early PAA patterning defects, we performed intracardial ink injection on E10.5 embryos. The PAAs were wellformed and patent in the majority of Wnt1-cre;Dgcr8 loxp/loxp embryos (n = 7/8) and in all of their control littermates (n = 24/24; Figs. 2A,B) . Therefore, ablation of Dgcr8 in cNCCs cells does not disrupt initial PAA formation (Lindsay, 2001) . We conclude that aortic arch malformations observed in Wnt1-cre;Dgcr8 loxp/loxp embryos develop after E10.5 and are likely related to the remodeling of the great vessels.
Normal migration of cNCCs into the OFT region
cNCCs migrate in trajectories that pass through PAAs into the cardiac OFT (Hutson and Kirby, 2007) . To evaluate cNCC migration we studied the expression of Crabp1 and Ap2-α, two NC markers. At E10.5, the expression pattern of these markers was comparable in Wnt1-cre;Dgcr8 loxp/loxp and control embryos (Figs. 2C-F), suggesting normal NC migration into the PAAs and OFT. We have substantiated our analysis of NC migration by genetic fate tracing, using Wnt1-cre;Dgcr8 loxp/loxp ;R26R-LacZ embryos. At E10.5 we were able to detect LacZ-positive Dgcr8 loxp/loxp ;Wnt1-cre;R26R-LacZ cNCC-descendants on their path into the PAAs and the cardiac OFT, that were indistinguishable from controls (Figs. 2G-L). However, two days later, at E12.5, we observed a significant reduction in LacZ expression of Wnt1-cre; Dgcr8 loxp/loxp cNCC-descendants in the developing OFT, relative to controls (Figs. 2M,N) . cNCCs enter the heart in two parallel prongs that are stereotypically positioned on opposite sides of the cardiac OFT (Hutson and Kirby, 2007) . In Wnt1-cre;Dgcr8 loxp/loxp OFT, the two prongs were malformed (Figs. 2M,N) . Plausibly, perturbed OFT morphogenesis was due to reduced cell numbers that first manifests between E10.5 and E12.5.
Normal smooth muscle differentiation and proliferation of cNCCs in the absence of Dgcr8.
Normal septum buildup and conotruncus remodeling requires that cNCCs-descendants will differentiate into vascular smooth muscle (Hutson and Kirby, 2007; Kirby et al., 1983) . To evaluate the impact of Dgcr8 ablation on cNCC differentiation into smooth muscle, we immunostained sections of the cardiac OFT with α-smooth muscle actin (SMA-α). This analysis revealed normal differentiation capacity of cNCCs into smooth muscle, even in the absence of Dgcr8 (Figs. 3A,B) .
DGCR8 is a regulator of cell cycle (Wang et al., 2007) , therefore we hypothesized that the reduction in cNCC numbers observed in E12.5 Wnt1-cre;Dgcr8 loxp/loxp OFTs could stem from impaired proliferation. However, 5-bromo-2′-deoxyuridine (BrdU) incorporation analysis revealed a comparable percentage of cNCC-descendants engaged in mitotic cell cycle at E10.5, E11.5 and E12.5, in both Wnt1-cre; Dgcr8 loxp/loxp and controls (Figs. 3C-E and unpublished data) . Thus, the apparent decrease in cell numbers observed at E12.5 mutant OFTs, is not due to inferior proliferation.
Inactivation of Dgrc8 in NCCs leads to elevated apoptosis
Loss of Dgcr8 was previously linked to enhanced apoptosis (Yi et al., 2009) , another potential reason for the disappearance of cNCCs in the OFTs of E12.5 Wnt1-cre;Dgcr8 loxp/loxp . Indeed, E10.5 Wnt1-cre; Dgcr8 loxp/loxp exhibited enhanced cleaved Caspase-3 staining in pharyngeal arches 1-4 and 6 (Figs. 4C,D), whilst control embryos exhibited only limited, physiological apoptosis (Figs. 4A,B) . Intriguingly, apoptosis of cNCC descendants was not identified at the OFT region (Figs. 4B,D,E) , suggesting rather unexpectedly, that cNCCs cells are susceptible to apoptosis at some positions along their journey but that post-migration they can survive without DGCR8 activity. When considered together, it appears that cNCCs normally migrate into the OFT region until E10.5 but reduced total cell numbers hampers normal morphogenesis of the aortic-pulmonary septum. This decrease in cell numbers is not due to inferior proliferation but because many Dgcr8-null cNCCs undergo apoptosis at the caudal pharyngeal arches, just before approaching the OFT region.
ERK signaling is attenuated in Dgcr8-null pharyngeal arches
In the pharyngeal arches, secreted FGF acts as a survival signal for migratory cNCCs through activation of an intracellular ERK cascade. Disruption of FGF/ERK signaling gives rise to cardiovascular malformations that are associated with DGS and are reminiscent of those observed in Wnt1-cre;Dgcr8 loxp/loxp mice (Frank et al., 2002; Krenz et al., 2008; Newbern et al., 2008) . Furthermore, loss of miRNA activity downstream of Dicer attenuates ERK signaling in NCCs (Huang et al., 2010) . Therefore, we examined the expression level of phosphorylated Erk1/2 proteins in Wnt1-cre;Dgcr8 loxp/loxp embryos. Our confocal analysis revealed significantly decreased expression of phosphorylated Erk1/2 in E10.5 Wnt1-cre;Dgcr8 loxp/loxp pharyngeal arches (Figs. 4F-K), reminiscent of the Dicer1-null phenotype and suggesting it as a likely contributing factor for apoptosis ( Figs. 4F-K) .
Taken together, our data provide in vivo evidence for Dgcr8 function in cardiovascular development and potentially associates Dgcr8, which is positioned in humans on chromosome 22q11.2, to DGS.
Discussion
Dgcr8 is annotated to the 22q11.2 microdeletion (Shiohama et al., 2003) and Dgcr8 heterozygous disruption results in behavioral and neuronal deficits characteristic of DGS (Schofield et al., 2011; Stark et al., 2008) . In DGS, cardiovascular structures are frequently affected, as a result of imperfect morphogenesis in embryonic stages (Ryan et al., 1997) , related to the contribution of cNCCs. In this work we used mouse genetics to study how loss of Dgcr8 in NCCs impinges on cardiovascular and pharyngeal development. Our data suggest that Dgcr8 is essential for the normal patterning of the OFT, since Wnt1-cre;Dgcr8 loxp/loxp embryos develop with cardiovascular defects reminiscent of those reported in humans, including in DGS patients. Accordingly, Dgcr8 mutants fail to remodel the conotruncus into independent aorta and pulmonary artery and exhibit VSD, interrupted aortic arch, and aberrant origin of the right subclavian artery.
Genetic fate mapping revealed normal early cNCCs migration into the OFT region at E10.5. However, many Dgcr8-null cNCCs undergo apoptosis at the caudal pharyngeal arches, just before approaching the OFT region. Thus, reduced total cell number hampers normal morphogenesis of the aortic-pulmonary septum and the ventricular septum.
FGF/ERK signaling provides essential survival cues for migratory NCCs. Furthermore, apoptosis was reported in migratory cNCCs of FGF hypomorphs, or when ERK was conditionally inactivated in NCCs (Frank et al., 2002; Krenz et al., 2008; Newbern et al., 2008) . We therefore suggest that the necessity for Dgcr8-dependant FGF/ ERK survival cues is restricted to the pharyngeal region. Intriguingly, cells that manage to inhabit the OFT, are protected from apoptosis, even if Dgcr8 ceases to be expressed. This further supports the role of FGF signaling in the Wnt1-cre;Dgcr8 loxp/loxp model, since the field of FGF activity is defined within the pharyngeal arches and does not extend into the OFT, as revealed by the expression domains of FGF downstream effectors, Pea3 and ERM (Chotteau-Lelievre et al., 2001; Mesbah et al., 2008) .
Dgcr8 effectors are very likely miRNA genes (Gregory et al., 2004; Han et al., 2004) . miRNA are involved in NCC migration, pharyngeal arch development and smooth muscle differentiation (Cordes et al., 2009; Small and Olson, 2011; Xin et al., 2009) . For example, miR-452 was recently shown to mediate non-cell-autonomous molecular crosstalk between the Shh and FGF signaling pathways in the first pharyngeal arch (Sheehy et al., 2010) . Similarly, miR-145 controls NCC differentiation into smooth muscle upstream of SRF and Myocardin (Cordes et al., 2009 ). These specific miRNAs may be intriguing effectors of DGCR8, both in mouse models and in human pathology.
Interestingly, conditional inactivation of Dicer1 in NCCs by a Wnt1-cre deleter caused OFT abnormalities that closely resemble the defects reported here (Huang et al., 2010; Sheehy et al., 2010) . In addition, ERK signaling is attenuated in the Wnt1-cre;Dicer1 model, (Huang et al., 2010) suggesting that the regulation of FGF signaling is likely mediated, intra-cellularly, by miRNAs in both mouse models. These results strongly suggest that Dgcr8 may work upstream of Dicer1 in cNCC development. Nonetheless, and quite surprisingly, in the Wnt1-cre;Dicer1 model, apoptosis was limited to the first pharyngeal arch but was not detected in the caudal pharyngeal arches or the OFT (Huang et al., 2010) . This difference maybe molecularly related to DICER1 activity in other pathways including: siRNA, heterochromatin, and functional silencing of toxic Alu transcripts, (Kaneko et al., 2011; Tam et al., 2008; Watanabe et al., 2008) which are independent of DGCR8 and miRNAs.
In summary, our study characterizes the essential role of Dgcr8, a Chr22q11.2 gene, in OFT morphogenesis and should motivate research of mutations in the Dgcr8 gene or specific miRNA genes in humans that manifest with cardiovascular defects.
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